CARDIOL THERAPEUTICS INC-A (CRDL) Stock Earnings Estimates
NASDAQ:CRDL • CA14161Y2006
1.005 USD
+0.02 (+1.93%)
Last: Feb 24, 2026, 04:30 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 80K | -100.00% | 12.99M | 52.313M 302.72% | 114.56M 118.99% | 249.3M 117.62% | 354.23M 42.09% | 521.09M 47.10% | 673.37M 29.22% | |||||||
| EBITDA YoY % growth | -13.98M -99.43% | -20.46M -46.35% | -38.44M -87.88% | -24.48M -6.97% | -23.46M 28.17% | -32.773M -35.10% | -30.806M 22.80% | -24.012M 22.05% | -21.18M 11.79% | -21.581M -1.89% | 10.752M 149.82% | 58.43M 443.43% | 157.11M 168.89% | 258.27M 64.39% | 307.34M 19.00% | |
| EBIT YoY % growth | -14.13M -99.01% | -20.69M -46.43% | -38.66M -86.85% | -39.79M -6.93% | -29.07M 27.95% | -40.494M -35.22% | -36.006M 10.60% | -31.81M 11.65% | -15.975M 49.78% | 18.378M 215.05% | 80.414M 337.56% | 185.34M 130.48% | 221.15M 19.32% | 312.55M 41.33% | 369.95M 18.37% | |
| Operating Margin | N/A | N/A | -48,325.00% | N/A | N/A | N/A | N/A | N/A | -122.98% | 35.13% | 70.19% | 74.34% | 62.43% | 59.98% | 54.94% | |
| EPS YoY % growth | N/A | N/A 12.54% | N/A -10.14% | -0.54 8.50% | -0.44 10.20% | -0.55 -15.91% | -0.40 22.00% | -0.57 -42.74% | -0.16 72.46% | 0.08 149.17% | 0.51 559.42% | 1.30 155.89% | 1.02 -21.07% | 1.68 64.07% | 2.01 19.53% |
All data in CAD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 9.33% | -0.11 -12.20% | -0.11 -12.20% | -0.11 6.50% | -0.11 -37.50% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.506M -5.17% | -9.894M -17.38% | -10.2M -32.88% | -10.71M -5.21% | -11.322M -7.77% |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.12 33.33% | -0.09 | -0.03 | -30.72% |
| Q2 2025 Q2Q % growth | -0.10 | -0.12 | 0.02 | 18.30% |
| Q1 2025 Q2Q % growth | -0.10 28.57% | -0.14 | 0.04 | 29.97% |
| Q4 2024 Q2Q % growth | -0.09 25.00% | -0.13 | 0.04 | 32.64% |
| Q3 2024 Q2Q % growth | -0.18 -100.00% | -0.12 | -0.06 | -47.06% |
| Q2 2024 Q2Q % growth | -0.10 16.67% | -0.13 | 0.03 | 24.59% |
| Q1 2024 Q2Q % growth | -0.14 -27.27% | -0.13 | -0.01 | -5.58% |
| Q4 2023 Q2Q % growth | -0.12 | -0.12 | 0.00 | 1.96% |
| Q3 2023 Q2Q % growth | -0.09 30.77% | -0.12 | 0.03 | 26.47% |
| Q2 2023 Q2Q % growth | -0.12 -20.00% | -0.13 | 0.01 | 5.88% |
| Q1 2023 Q2Q % growth | -0.11 21.43% | -0.15 | 0.04 | 28.10% |
| Q4 2022 Q2Q % growth | -0.12 -9.09% | -0.16 | 0.04 | 24.10% |
| Q3 2022 Q2Q % growth | -0.13 8.96% | -0.15 | 0.02 | 12.10% |
| Q2 2022 Q2Q % growth | -0.10 37.50% | -0.14 | 0.04 | 29.97% |
| Q1 2022 Q2Q % growth | -0.14 46.15% | -0.17 | 0.03 | 19.26% |
| Q4 2021 Q2Q % growth | -0.11 26.67% | -0.15 | 0.04 | 28.10% |
| Q2 2021 Q2Q % growth | -0.16 | -0.14 | -0.02 | -12.04% |
| Q1 2021 Q2Q % growth | -0.26 -136.36% | -0.14 | -0.12 | -82.07% |
| Q4 2020 Q2Q % growth | -0.15 | -0.12 | -0.03 | -22.55% |
| Q1 2020 Q2Q % growth | -0.11 | -0.16 | 0.05 | 32.60% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | 306K | -306K | -100.00% | |
| Q2 2021 Q2Q % growth | 80K | 204K | -124K | -60.78% |
| Q1 2021 Q2Q % growth | 51K | -51K | -100.00% | |
| Q4 2020 Q2Q % growth | 255K | -255K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -14.29% | 0% | -6.85% |
| Revenue | N/A | N/A | N/A | N/A |